{"doi":"10.1046\/j.1365-2249.2003.02026.x","coreId":"136143","oai":"oai:bradscholars.brad.ac.uk:10454\/4027","identifiers":["oai:bradscholars.brad.ac.uk:10454\/4027","10.1046\/j.1365-2249.2003.02026.x"],"title":"The role of somatic mutation in determining the affinity of anti-DNA antibodies.","authors":["Behrendt, M.","Partridge, L. J.","Griffiths, B","Goodfield, M.","Snaith, M.","Lindsey, Nigel J."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2003","abstract":"noCombinatorial antibody libraries were constructed from the spleen of a patient with concomitant systemic lupus erythematosus and idiopathic thrombocytopenia. Following selection of the libraries with DNA, a panel of 15 anti-DNA Fabs was isolated. Sequence analysis of these antibodies coupled with measurements of their affinities for ss- and dsDNA were used to investigate the role of somatic mutation in affinity maturation of the anti-DNA response. Examination of the germline genes used by these Fabs supports previous studies that suggest there is no restriction of the gene usage in the anti-DNA response. However, data are presented indicating that VH3 genes and the A27 V\u00bf paired with the J\u00bf1 may be over-expressed in the anti-DNA repertoire. Analysis of the role of somatic mutation in increasing affinity for DNA indicates that affinity maturation has occurred and suggests that the CDR1 and CDR2 of the heavy chain are of importance in this process","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Wiley","rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/4027<\/identifier><datestamp>\n                2014-05-20T09:32:53Z<\/datestamp><setSpec>\n                com_10454_413<\/setSpec><setSpec>\n                col_10454_6345<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nThe role of somatic mutation in determining the affinity of anti-DNA antibodies.<\/dc:title><dc:creator>\nBehrendt, M.<\/dc:creator><dc:creator>\nPartridge, L. J.<\/dc:creator><dc:creator>\nGriffiths, B<\/dc:creator><dc:creator>\nGoodfield, M.<\/dc:creator><dc:creator>\nSnaith, M.<\/dc:creator><dc:creator>\nLindsey, Nigel J.<\/dc:creator><dc:subject>\nHuman spleen<\/dc:subject><dc:subject>\nLupus erythematosus<\/dc:subject><dc:subject>\nAutoantibodies<\/dc:subject><dc:subject>\nAutoimmunity<\/dc:subject><dc:subject>\nSomatic mutation<\/dc:subject><dc:description>\nno<\/dc:description><dc:description>\nCombinatorial antibody libraries were constructed from the spleen of a patient with concomitant systemic lupus erythematosus and idiopathic thrombocytopenia. Following selection of the libraries with DNA, a panel of 15 anti-DNA Fabs was isolated. Sequence analysis of these antibodies coupled with measurements of their affinities for ss- and dsDNA were used to investigate the role of somatic mutation in affinity maturation of the anti-DNA response. Examination of the germline genes used by these Fabs supports previous studies that suggest there is no restriction of the gene usage in the anti-DNA response. However, data are presented indicating that VH3 genes and the A27 V\u00bf paired with the J\u00bf1 may be over-expressed in the anti-DNA repertoire. Analysis of the role of somatic mutation in increasing affinity for DNA indicates that affinity maturation has occurred and suggests that the CDR1 and CDR2 of the heavy chain are of importance in this process.<\/dc:description><dc:date>\n2009-12-03T15:44:05Z<\/dc:date><dc:date>\n2009-12-03T15:44:05Z<\/dc:date><dc:date>\n2003<\/dc:date><dc:type>\nArticle<\/dc:type><dc:type>\npublished version paper<\/dc:type><dc:identifier>\nBehrendt, M., Partridge, L. J., Griffiths, B., Goodfield, M., Snaith, M. and Lindsey, N. J. (2003) Clinical & Experimental Immunology, Vol. 131, No. 1, pp. 182-189.<\/dc:identifier><dc:identifier>\n90010580<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/4027<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1046\/j.1365-2249.2003.02026.x<\/dc:relation><dc:publisher>\nWiley<\/dc:publisher>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1046\/j.1365-2249.2003.02026.x"],"year":2003,"topics":["Human spleen","Lupus erythematosus","Autoantibodies","Autoimmunity","Somatic mutation"],"subject":["Article","published version paper"],"fullText":null}